Frank della Fera
Direktor/Vorstandsmitglied bei LSL PHARMA GROUP INC.
Vermögen: 383 979 $ am 30.04.2024
Profil
Mr. Frank J.
della Fera is a President & Chief Executive Officer at Fera Pharmaceuticals LLC.
He is on the Board of Directors at LSL Pharma Group, Inc. Mr. della Fera was previously employed as a Vice President-Sales & Marketing by Eon Labs, Inc., a Principal by Ben Venue Laboratories, Inc., a Sales Director by Dura Pharmaceuticals, Inc., a Principal by Eli Lilly & Co., and a President & Chief Executive Officer by Sandoz, Inc. He also served on the board at Grenville Baker Boys & Girls Club, Inc. He received his undergraduate degree from St. John's University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LSL PHARMA GROUP INC
1,57% | 23.04.2024 | 1 292 857 ( 1,57% ) | 383 979 $ | 30.04.2024 |
Aktive Positionen von Frank della Fera
Unternehmen | Position | Beginn |
---|---|---|
LSL PHARMA GROUP INC. | Direktor/Vorstandsmitglied | - |
Fera Pharmaceuticals LLC
Fera Pharmaceuticals LLC BiotechnologyHealth Technology Fera Pharmaceuticals LLC is a privately held specialty pharmaceutical company located in the US. The American company's goal is to realize opportunities through acquisitions, in-licensing, and developing and marketing various drug applications. Fera Pharmaceuticals is committed to expanding treatment choices in ophthalmology and other therapeutic areas, with a focus on niche markets. The CEO of the company is Frank J. della Fera. | Vorstandsvorsitzender | 01.01.2005 |
Ehemalige bekannte Positionen von Frank della Fera
Unternehmen | Position | Ende |
---|---|---|
Eon Labs, Inc.
Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Vertrieb & Marketing | 01.01.2005 |
Grenville Baker Boys & Girls Club, Inc. | Direktor/Vorstandsmitglied | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Vorstandsvorsitzender | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Corporate Officer/Principal | - |
Ausbildung von Frank della Fera
St. John's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
LSL PHARMA GROUP INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Health Technology |
Eon Labs, Inc.
Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Grenville Baker Boys & Girls Club, Inc. | |
Fera Pharmaceuticals LLC
Fera Pharmaceuticals LLC BiotechnologyHealth Technology Fera Pharmaceuticals LLC is a privately held specialty pharmaceutical company located in the US. The American company's goal is to realize opportunities through acquisitions, in-licensing, and developing and marketing various drug applications. Fera Pharmaceuticals is committed to expanding treatment choices in ophthalmology and other therapeutic areas, with a focus on niche markets. The CEO of the company is Frank J. della Fera. | Health Technology |